[go: up one dir, main page]

LT3431590T - Aktyvinto hepatocitų augimo faktoriaus (hgfa) gamybos būdas - Google Patents

Aktyvinto hepatocitų augimo faktoriaus (hgfa) gamybos būdas

Info

Publication number
LT3431590T
LT3431590T LTEPPCT/JP2017/010355T LTJP2017010355T LT3431590T LT 3431590 T LT3431590 T LT 3431590T LT JP2017010355 T LTJP2017010355 T LT JP2017010355T LT 3431590 T LT3431590 T LT 3431590T
Authority
LT
Lithuania
Prior art keywords
hepatococytic
hgfa
activated
production
growth factor
Prior art date
Application number
LTEPPCT/JP2017/010355T
Other languages
English (en)
Inventor
Masashi Shimizu
Toshitaka Sato
Yoshihisa Arita
Original Assignee
Eisai R&D Management Co., Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai R&D Management Co., Ltd. filed Critical Eisai R&D Management Co., Ltd.
Publication of LT3431590T publication Critical patent/LT3431590T/lt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/48Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/48Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424Serine endopeptidases (3.4.21)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475Growth factors; Growth regulators
    • C07K14/4753Hepatocyte growth factor; Scatter factor; Tumor cytotoxic factor II
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10Cells modified by introduction of foreign genetic material
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/96Stabilising an enzyme by forming an adduct or a composition; Forming enzyme conjugates
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • C12P21/02Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y304/00Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21Serine endopeptidases (3.4.21)
    • C12Y304/21034Plasma kallikrein (3.4.21.34)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y304/00Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21Serine endopeptidases (3.4.21)
    • C12Y304/21073Serine endopeptidases (3.4.21) u-Plasminogen activator (3.4.21.73), i.e. urokinase

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Cell Biology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
LTEPPCT/JP2017/010355T 2016-03-17 2017-03-15 Aktyvinto hepatocitų augimo faktoriaus (hgfa) gamybos būdas LT3431590T (lt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2016054128 2016-03-17
PCT/JP2017/010355 WO2017159722A1 (ja) 2016-03-17 2017-03-15 活性型肝細胞増殖因子(hgf)の製造方法

Publications (1)

Publication Number Publication Date
LT3431590T true LT3431590T (lt) 2021-09-10

Family

ID=59850449

Family Applications (1)

Application Number Title Priority Date Filing Date
LTEPPCT/JP2017/010355T LT3431590T (lt) 2016-03-17 2017-03-15 Aktyvinto hepatocitų augimo faktoriaus (hgfa) gamybos būdas

Country Status (16)

Country Link
US (3) US11548926B2 (lt)
EP (1) EP3431590B1 (lt)
JP (1) JP6861201B2 (lt)
KR (1) KR102275262B1 (lt)
CN (1) CN109196099B (lt)
AU (1) AU2017232582B2 (lt)
CA (1) CA3014567C (lt)
DK (1) DK3431590T3 (lt)
ES (1) ES2894477T3 (lt)
HU (1) HUE055414T2 (lt)
IL (1) IL261066B (lt)
LT (1) LT3431590T (lt)
MX (1) MX395311B (lt)
RU (1) RU2747977C2 (lt)
SG (1) SG11201806843UA (lt)
WO (1) WO2017159722A1 (lt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017159722A1 (ja) 2016-03-17 2017-09-21 エーザイ・アール・アンド・ディー・マネジメント株式会社 活性型肝細胞増殖因子(hgf)の製造方法
CN110606883A (zh) * 2019-07-25 2019-12-24 广州凌腾生物医药有限公司 肝细胞生长因子的制备方法
CN110607304A (zh) * 2019-07-25 2019-12-24 广州凌腾生物医药有限公司 肝细胞生长因子的重组表达方法
WO2024096038A1 (ja) * 2022-11-01 2024-05-10 クリングルファーマ株式会社 活性型hgfの製造方法

Family Cites Families (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2564486B2 (ja) 1986-07-14 1996-12-18 修治 橋本 肝細胞増殖因子
NZ232813A (en) 1989-03-10 1992-08-26 Snow Brand Milk Products Co Ltd Human fibroblast glycoprotein, cell differentiation, blood vessel endothelial cell growth factor, cellular immunology inforcing factor of 78 or 74 thousand daltons plus or minus two thousand daltons
JP2706704B2 (ja) 1989-06-05 1998-01-28 敏一 中村 組換ヒト肝実質細胞増殖因子
JP2577091B2 (ja) 1989-08-11 1997-01-29 三菱化学株式会社 肝実質細胞増殖因子及びそれをコードする遺伝子
JP3036782B2 (ja) 1990-04-03 2000-04-24 三菱化学株式会社 ヒト肝実質細胞増殖因子の生産方法および該因子を産生する形質転換体
JP2777678B2 (ja) 1990-06-11 1998-07-23 敏一 中村 組換ヒト肝実質細胞増殖因子及びその製造方法
JP3072628B2 (ja) 1990-11-19 2000-07-31 敏一 中村 ヒト肝実質細胞増殖因子をコードする染色体dna
JP3213985B2 (ja) 1991-10-18 2001-10-02 三菱化学株式会社 新規なタンパク質
JP3232714B2 (ja) 1992-11-20 2001-11-26 三菱化学株式会社 新規なタンパク質およびそれをコードする遺伝子
CA2102463A1 (en) * 1992-11-05 1994-05-06 Mitsubishi Chemical Corporation Protein and gene encoding said protein
WO1994019020A1 (en) 1993-02-23 1994-09-01 Genentech, Inc. Excipient stabilization of polypeptides treated with organic solvents
JP2577091Y2 (ja) 1993-06-23 1998-07-23 賢一 片山 分流装置の合成樹脂製サドル
JP3680114B2 (ja) * 1993-09-17 2005-08-10 敏一 中村 脳神経障害治療剤
JP2747979B2 (ja) 1994-08-19 1998-05-06 雪印乳業株式会社 ヒト由来の糖蛋白質からなる生理活性因子を有効成分とする医薬
JP3927248B2 (ja) 1995-07-11 2007-06-06 第一製薬株式会社 Hgf凍結乾燥製剤
JP2859577B2 (ja) 1996-03-27 1999-02-17 三菱化学株式会社 肝実質細胞増殖因子
JP4463885B2 (ja) 1996-12-05 2010-05-19 敏一 中村 劇症肝炎疾患治療剤
JP2980888B2 (ja) 1998-07-09 1999-11-22 三菱化学株式会社 肝実質細胞増殖因子をコードする遺伝子
CN100448482C (zh) 1999-05-31 2009-01-07 三菱化学株式会社 Hgf冻干制剂
JP3072628U (ja) 2000-02-17 2000-10-24 輝夫 尾形 ステンドグラス製文字入り記念楯
JP4090236B2 (ja) * 2000-12-05 2008-05-28 三菱化学株式会社 活性型肝細胞増殖因子アクティベーターに対する特異的抗体とその使用法
US7045602B2 (en) * 2000-12-05 2006-05-16 Mitsubishi Chemical Corporation Specific antibody directed to active hepatocyte growth factor activator and method for using the same
DE10204792A1 (de) 2002-02-06 2003-08-14 Merck Patent Gmbh Lyophilisierte Zubereitung enthaltend Immuncytokine
CA2570323C (en) 2004-07-26 2014-08-26 Genentech, Inc. Methods and compositions for modulating hepatocyte growth factor activation
US7741096B2 (en) * 2004-12-10 2010-06-22 Genentech, Inc. Crystal structure of hepatocyte growth factor activator complexed with Kunitz domain inhibitor
BRPI0618488A2 (pt) * 2005-11-10 2011-08-30 Receptor Biologix Inc proteìnas de fusão de ìntron de fator de crescimento de hepatócito
JP5093783B2 (ja) 2006-04-20 2012-12-12 クリングルファーマ株式会社 Hgf前駆体蛋白質改変体及びその活性型蛋白質
WO2008078189A2 (en) 2006-12-20 2008-07-03 Bayer Healthcare Llc Factor vii and viia compositions
WO2008102452A1 (ja) 2007-02-22 2008-08-28 Kringle Pharma Inc. Hgf製剤
US9393304B2 (en) 2008-10-29 2016-07-19 Ablynx N.V. Formulations of single domain antigen binding molecules
CN101649320B (zh) * 2009-09-15 2011-06-15 上海交通大学医学院附属仁济医院 重组人源hgf激活因子及其应用
KR20120106940A (ko) * 2009-10-19 2012-09-27 제넨테크, 인크. 간세포 성장 인자 활성화제의 조절제
WO2011102845A1 (en) 2010-02-18 2011-08-25 Transtech Pharma, Inc. Rage fusion protein compositions and methods of use
JP2012051822A (ja) 2010-08-31 2012-03-15 Institute Of Physical & Chemical Research 肺癌診断用ポリペプチド、肺癌の検出方法、および治療効果の評価方法
US9272018B2 (en) 2011-04-18 2016-03-01 Kyoto University Acute hepatic insufficiency depressant and method for evaluating drug efficacy thereof
US20130071931A1 (en) 2011-08-02 2013-03-21 National Cancer Center Process for hepatic differentiation from induced hepatic stem cells, and induced hepatic progenitor cells differentiated thereby
AU2013201422B2 (en) * 2012-01-23 2015-04-09 Ablynx Nv Sequences directed against hepatocyte growth factor (HFG) and polypeptides comprising the same for the treatment of cancers and/or tumors
CN105209074A (zh) 2012-10-20 2015-12-30 得克萨斯大学体系董事会 癌细胞陷阱
RU2506946C1 (ru) 2012-11-28 2014-02-20 Государственное бюджетное образовательное учреждение высшего профессионального образования "Воронежская государственная медицинская академия им. Н.Н. Бурденко" Министерства здравоохранения и социального развития Российской Федерации Технология лиофилизации обогащенной тромбоцитами плазмы с сохранением жизнеспособности факторов tgf pdgf vegf
TWI728409B (zh) 2014-04-28 2021-05-21 日商衛材R&D企管股份有限公司 Hgf冷凍乾燥製劑
WO2017159722A1 (ja) 2016-03-17 2017-09-21 エーザイ・アール・アンド・ディー・マネジメント株式会社 活性型肝細胞増殖因子(hgf)の製造方法
JP6800208B2 (ja) 2016-03-18 2020-12-16 エーザイ・アール・アンド・ディー・マネジメント株式会社 肝細胞増殖因子(hgf)のpdマーカー
CN208371461U (zh) 2017-08-21 2019-01-15 潍坊鸿旺工贸有限公司 一种晾衣架用连接构件及晾衣架

Also Published As

Publication number Publication date
EP3431590A4 (en) 2019-11-20
US20190062390A1 (en) 2019-02-28
CA3014567C (en) 2024-02-20
US12384824B2 (en) 2025-08-12
IL261066B (en) 2021-08-31
US11548926B2 (en) 2023-01-10
RU2747977C2 (ru) 2021-05-18
RU2018130530A (ru) 2020-04-17
EP3431590A1 (en) 2019-01-23
SG11201806843UA (en) 2018-09-27
KR20180127322A (ko) 2018-11-28
JPWO2017159722A1 (ja) 2019-01-24
AU2017232582B2 (en) 2022-07-14
AU2017232582A1 (en) 2018-08-30
WO2017159722A1 (ja) 2017-09-21
JP6861201B2 (ja) 2021-04-21
ES2894477T3 (es) 2022-02-14
RU2018130530A3 (lt) 2020-08-13
KR102275262B1 (ko) 2021-07-12
EP3431590B1 (en) 2021-07-28
MX395311B (es) 2025-03-25
HUE055414T2 (hu) 2021-11-29
US20240218035A1 (en) 2024-07-04
MX2018010283A (es) 2019-01-31
CA3014567A1 (en) 2017-09-21
US20220267393A1 (en) 2022-08-25
CN109196099B (zh) 2022-01-11
CN109196099A (zh) 2019-01-11
IL261066A (en) 2018-10-31
DK3431590T3 (da) 2021-10-11

Similar Documents

Publication Publication Date Title
PL3490395T3 (pl) Sposób wytwarzania aerozolu
HUE057926T2 (hu) Eljárás tiokarbonátok elõállítására
JP2016208024A5 (ja) 電極の作製方法
PL3325443T3 (pl) Sposób otrzymywania pridopidyny
HUE060248T2 (hu) Eljárás növényi kivonatok elõállítására
EP3666729C0 (en) PROCESS FOR THE PRODUCTION OF NANO-SULFUR
DK3377201T3 (da) Fremgangsmåde til fremstilling af membraner
LT3271347T (lt) Priešgrybeliniai junginiai ir jų gamybos būdai
ES2864754T8 (es) Método de producción de metionina
PL3420424T3 (pl) Sposób przeprowadzania cyklicznych procesow produkcyjnych
IL269651A (en) Improved method of producing collagenase
PL3416936T3 (pl) Sposób wytwarzania metanolu
DK3166904T3 (da) Fremgangsmåde til fremstilling af betonelementer
PL3630738T3 (pl) Sposób wytwarzania ozanimodu
IL250589B (en) Electrode for electrochlorination processes and method of manufacturing thereof
DK3147369T3 (da) Fremgangsmåde til produktion af fibroinlignende protein
PL3548473T3 (pl) Sposób wytwarzania hmf
EP3323166A4 (en) AUTOMATED MANUFACTURE OF A BIONANO CATALYST
HUE056799T2 (hu) Módszer specifikus természetes kapszaicinoidok mikrobiális elõállítására
EP4046129C0 (fr) Procédé de fabrication
DK3443110T3 (da) Fermenteringsproces til fremstilling af maltosyl-isomalto-oligosaccharider (mimo)
IL284374A (en) Methods of producing ustekinumab
PL3717523T3 (pl) Sposób modyfikacji ldpe
PL3176152T3 (pl) Sposób wytwarzania mocznika
LT3431590T (lt) Aktyvinto hepatocitų augimo faktoriaus (hgfa) gamybos būdas